GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Loans Receivable

DT&CRO Co (XKRX:383930) Loans Receivable : ₩0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Loans Receivable?

DT&CRO Co's Loans Receivable for the quarter that ended in Mar. 2024 was ₩0 Mil.


DT&CRO Co Loans Receivable Historical Data

The historical data trend for DT&CRO Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Loans Receivable Chart

DT&CRO Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Loans Receivable
- - - -

DT&CRO Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

DT&CRO Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


DT&CRO Co Loans Receivable Related Terms

Thank you for viewing the detailed overview of DT&CRO Co's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


DT&CRO Co (XKRX:383930) Business Description

Traded in Other Exchanges
N/A
Address
28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines